286 related articles for article (PubMed ID: 33081171)
21. MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc.
Yuan J; Wang K; Xi M
Med Sci Monit; 2016 Feb; 22():617-24. PubMed ID: 26908019
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
23. Nerve Growth Factor (NGF) Encourages the Neuroinvasive Potential of Pancreatic Cancer Cells by Activating the Warburg Effect and Promoting Tumor Derived Exosomal miRNA-21 Expression.
Peng T; Guo Y; Gan Z; Ling Y; Xiong J; Liang X; Cui J
Oxid Med Cell Longev; 2022; 2022():8445093. PubMed ID: 36285300
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA NORAD is upregulated in epithelial ovarian cancer and its downregulation suppressed cancer cell functions by competing with miR-155-5p.
Tong L; Ao Y; Zhang H; Wang K; Wang Y; Ma Q
Cancer Med; 2019 Aug; 8(10):4782-4791. PubMed ID: 31250987
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-145 function as a cell growth repressor by directly targeting c-Myc in human ovarian cancer.
Zhang W; Wang Q; Yu M; Wu N; Wang H
Technol Cancer Res Treat; 2014 Apr; 13(2):161-8. PubMed ID: 23919393
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
[TBL] [Abstract][Full Text] [Related]
27. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1.
Gong YB; Fan XH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
29. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number.
Woo CW; Lucarelli E; Thiele CJ
Oncogene; 2004 Feb; 23(8):1522-30. PubMed ID: 14691455
[TBL] [Abstract][Full Text] [Related]
30. NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE
Garrido MP; Hurtado I; Valenzuela-Valderrama M; Salvatierra R; Hernández A; Vega M; Selman A; Quest AFG; Romero C
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817839
[TBL] [Abstract][Full Text] [Related]
31. NGF increases VEGF expression and promotes cell proliferation via ERK1/2 and AKT signaling in Müller cells.
Wang J; He C; Zhou T; Huang Z; Zhou L; Liu X
Mol Vis; 2016; 22():254-63. PubMed ID: 27081296
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
[TBL] [Abstract][Full Text] [Related]
33. Role of nerve growth factor and its TRKA receptor in normal ovarian and epithelial ovarian cancer angiogenesis.
Vera C; Tapia V; Vega M; Romero C
J Ovarian Res; 2014 Aug; 7():82. PubMed ID: 25296882
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.
Wei C; Zhang X; He S; Liu B; Han H; Sun X
Gene; 2017 Dec; 637():25-32. PubMed ID: 28890378
[TBL] [Abstract][Full Text] [Related]
35. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
[TBL] [Abstract][Full Text] [Related]
36. The activation of microRNA-520h-associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression.
Zhang J; Liu W; Shen F; Ma X; Liu X; Tian F; Zeng W; Xi X; Lin Y
Cell Death Dis; 2018 Aug; 9(9):884. PubMed ID: 30158641
[TBL] [Abstract][Full Text] [Related]
37. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Davidson B; Reich R; Lazarovici P; Nesland JM; Skrede M; Risberg B; Tropé CG; Flørenes VA
Clin Cancer Res; 2003 Jun; 9(6):2248-59. PubMed ID: 12796393
[TBL] [Abstract][Full Text] [Related]
38. Nerve growth factor induces the expression of chaperone protein calreticulin in human epithelial ovarian cells.
Vera C; Tapia V; Kohan K; Gabler F; Ferreira A; Selman A; Vega M; Romero C
Horm Metab Res; 2012 Jul; 44(8):639-43. PubMed ID: 22773372
[TBL] [Abstract][Full Text] [Related]
39. The role of the long non-coding RNA TDRG1 in epithelial ovarian carcinoma tumorigenesis and progression through miR-93/RhoC pathway.
Chen S; Wang LL; Sun KX; Xiu YL; Zong ZH; Chen X; Zhao Y
Mol Carcinog; 2018 Feb; 57(2):225-234. PubMed ID: 28984384
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.
Zhang J; Liu L; Sun Y; Xiang J; Zhou D; Wang L; Xu H; Yang X; Du N; Zhang M; Yan Q; Xi X
Oncotarget; 2016 May; 7(18):26516-34. PubMed ID: 27049921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
